A Pharmaceuticals (Formulation) entity from India is looking to sellout.
BUSINESS BRIEF
Below is a brief detail about the company:
1. Why do they want to sell the Company? Financial Support and Clear the Debt of Banks
2. Current Company Name and Address: (will be shared later)
3. Company Incorporation Year: 1994, Started Operation in December 2018, In the meantime, they were doing some paperwork. In 2010, the Current Directors have been appointed.
Earlier Directors only obtained the land
4. Plant Built-Up Area- 23,500 Square Foot
5. Land Area- 1000 Square Meter +1280 Square Meter open plot
6. What are the products they manufacture? pellets and capsules in various combinations- Anti Allergic, Anti Fungal, Anti Acidic, cold Cough, and many other
7. Capacity- 30 MT pellets per month, 6 crore Capsules per month 8. Number of Products- More than 40 Products
9. What Domestic and International Approval do they have? WHO GMP Certified Company valid till June 2023
10. Export in International Market- Yes/ No- Yes
11. If yes, what are the countries? Bangladesh, Nigeria, Ghana, Vietnam, Syria 12. Manpower- Skilled Workers- 40, Unskilled Workers- 20, Administration- 20
13. Last 3 years revenue (only numbers are required): 1st Year- INR 2.5 crore, 2nd Year- INR 3.75 crore, 3rd Year- 4.75 crore, Current Year Approximate- INR 10-15 crore.
14. Profit Margin in % last three years: This is a new company and it will take at least another one year to convert into profits 20% to 45% depending upon the product
15. Shareholding Pattern (in %): 3 Directors, MD- 85%, other two Directors- total 15% 16. Current Debt/ loan: Bank Loan- INR 15 crore, Unsecured Loan- INR 7 crore
17. Selling Price (INR): INR 40 crore
18. Maximum Equity the company will offer (in %): We are looking for 50% Equity or 100% Sell Out; open to negotiate the best way possible
Proposal
Industry
Pharmaceuticals
Sub Industry
Formulation
Deal Size
INR 40 - 45 Cr
Motives For Sellout
Raising Capital, Curtailment of losses, Strategic Realignment
Management is open to continue with the business for handholding the new investor/buyers
Business Operation Information
Industry
Pharmaceuticals
Sub-Industry
Formulation
Division
Formulation Type
Financial Information |
2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) | 2021 (in Cr) |
---|---|---|---|---|
Sales |
INR 1 Cr | INR 1 Cr | INR 1 Cr | INR 1 Cr |
EBITDA |
N.D | N.D | N.D | N.D |
PAT |
N.D | N.D | N.D | N.D |
TOTAL DEBT |
N.D | N.D | N.D | N.D |